GRI Bio (GRI) Non-Current Assets (2020 - 2026)
GRI Bio's Non-Current Assets was $46,000 in Q2 2026, down 53.5% from $99,000 a year earlier and down 23.3% from the prior quarter.
Powered by 
Analysis
GRI Bio (GRI) Non-Current Assets (2020 - 2026) Analysis & Trends
At the end of FY2025, Non-Current Assets at GRI Bio came in at $74,000, down 40.3% from FY2024.
- Non-Current Assets shows a five-year compound annual growth rate of -23.4% (FY2020 to FY2025).
- In earlier years, Non-Current Assets was $124,000 in FY2024 (+463.6%), $22,000 in FY2023 (-69.0%), $71,000 in FY2022 (-65.5%) and $206,000 in FY2021 (-26.7%).
- The Q2 2026 figure marks the lowest quarterly Non-Current Assets since Q4 2023.
- Compared with a year earlier, Non-Current Assets has declined for six straight quarters, with growth averaging 61.4% over the last eight quarters.
- The best year-over-year quarter for Non-Current Assets over five years was Q4 2024 (growth of 463.6%); the worst was Q2 2023 (a decline of 70.4%).
- Per Business Quant data, GRI's Non-Current Assets in the three quarters before Q2 2026 was $60,000 (Q1 2026), $74,000 (Q4 2025) and $85,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,130.22 Bn | 1,098.80 Bn | 19.71 Bn | 77.61 Bn |
| 2 | Johnson & Johnson | 614.95 Bn | 533.47 Bn | 17.26 Bn | 141.29 Bn |
| 3 | AbbVie | 505.05 Bn | 478.16 Bn | 12.70 Bn | 101.45 Bn |
| 4 | Merck | 368.08 Bn | 322.46 Bn | 12.21 Bn | 125.00 Mn |
| 5 | Novartis Ag | 298.32 Bn | 262.31 Bn | 11.24 Bn | 94.68 Bn |
| 6 | Astrazeneca | 261.58 Bn | 235.26 Bn | 12.86 Bn | 87.87 Bn |
| 7 | Amgen | 236.05 Bn | 191.45 Bn | 7.24 Bn | 60.68 Bn |
| 8 | Gilead Sciences | 190.61 Bn | 164.80 Bn | 6.22 Bn | 35.42 Bn |
| 9 | Pfizer | 169.86 Bn | 116.50 Bn | 10.94 Bn | 159.77 Bn |
| 10 | GRI Bio | 2.80 Mn | -31.48 Mn | - | 46,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 46,000.00 |
| Mar 31, 2026 | 60,000.00 |
| Dec 31, 2025 | 74,000.00 |
| Sep 30, 2025 | 85,000.00 |
| Jun 30, 2025 | 99,000.00 |
| Mar 31, 2025 | 112,000.00 |
| Dec 31, 2024 | 124,000.00 |
| Sep 30, 2024 | 136,000.00 |
| Jun 30, 2024 | 147,000.00 |
| Mar 31, 2024 | 159,000.00 |
| Dec 31, 2023 | 22,000.00 |
| Sep 30, 2023 | 37,000.00 |
| Jun 30, 2023 | 50,000.00 |
| Dec 31, 2022 | 71,000.00 |
| Jun 30, 2022 | 169,000.00 |
| Mar 31, 2022 | 187,000.00 |
| Dec 31, 2021 | 206,000.00 |
| Sep 30, 2021 | 224,000.00 |
| Jun 30, 2021 | 243,000.00 |
| Mar 31, 2021 | 262,000.00 |
API Access
GRI Bio Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=GRI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "GRI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=GRI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();